Lei Panpan, Ma Weina, Gao Jiapan, Ren Bingxi, Ma Xiaoyu, Zhang Yuxiu, Su Xinyue, Liang Jinna, He Langchong
School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China.
State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, Xi'an, 710061, People's Republic of China.
Arch Pharm Res. 2025 Jan;48(1):102-114. doi: 10.1007/s12272-024-01525-x. Epub 2024 Dec 10.
The specific binding of a drug to the receptor is a prerequisite for its action. The equilibrium dissociation constant (K) is an important parameter for measuring the strength of drug-receptor interactions. Cell membrane chromatography (CMC) is a powerful way to determine the K value; however, the common disadvantage is that the attenuation of biological activity with the analysis process leads to corresponding errors in comparing K values of a series of drugs. Therefore, it is of practical significance to analyze the relative K values of drugs for the same membrane receptor under the same conditions. We developed a CMC relative competitive method to determine the relative K values of drugs through simultaneous injection of the control compound and analyte in each analysis, circumventing the error in K values of drugs due to the attenuation of the biological activity of the CMC column. The results showed that the K values of CD147 antagonists and MRGPRX2 agonists determined using the CMC relative competitive method correlated well with the K values obtained via frontal analysis and stepwise frontal method using the CD147 (MRGPRX2)/CMC system. Critically, the biological activities of the CD147 antagonists and MRGPRX2 agonists were significantly correlated with K values measured using the CMC relative competitive method. Therefore, the CMC relative competitive method can accurately and efficiently evaluate the relative K values of drugs and effectively predict the differences in pharmacological activity between a series of drugs, which has important guiding significance in the development of targeted drugs.
药物与受体的特异性结合是其发挥作用的前提条件。平衡解离常数(K)是衡量药物 - 受体相互作用强度的重要参数。细胞膜色谱法(CMC)是测定K值的有效方法;然而,其普遍缺点是随着分析过程生物活性的衰减会导致一系列药物K值比较时产生相应误差。因此,在相同条件下分析同一膜受体药物的相对K值具有实际意义。我们开发了一种CMC相对竞争法,通过在每次分析中同时注入对照化合物和分析物来测定药物的相对K值,避免了由于CMC柱生物活性衰减导致的药物K值误差。结果表明,使用CMC相对竞争法测定的CD147拮抗剂和MRGPRX2激动剂的K值与使用CD147(MRGPRX2)/CMC系统通过前沿分析和逐步前沿法获得的K值具有良好的相关性。至关重要的是,CD147拮抗剂和MRGPRX2激动剂的生物活性与使用CMC相对竞争法测定的K值显著相关。因此,CMC相对竞争法能够准确、高效地评估药物的相对K值,并有效预测一系列药物之间的药理活性差异,这在靶向药物开发中具有重要的指导意义。